Comparison between Fourth Dimension Solutions IPO and Ganga Pharmaceuticals IPO.
Fourth Dimension Solutions IPO is a SME Fixed Price IPO proposed to list at NSE SME while Ganga Pharmaceuticals IPO is a SME Fixed Price proposed to list at BSE SME.
| Fourth Dimension Solutions IPO | Ganga Pharmaceuticals IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Sarthi Capital Advisors Pvt.Ltd. | First Overseas Capital Ltd. |
| Registrar | Sharepro Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Wealth First Portfolio Managers Pvt.Ltd. | Alacrity Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Fourth Dimension Solutions IPO is up to ₹8.23 Cr whereas the issue size of the Ganga Pharmaceuticals IPO is up to ₹1.54 Cr. The final issue price of Fourth Dimension Solutions IPO is ₹30.00 per share and of Ganga Pharmaceuticals IPO is ₹15.00 per share.
| Fourth Dimension Solutions IPO | Ganga Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Final) | ₹30.00 per share | ₹15.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Market Lot Size | 4000 shares | 8000 shares |
| Fresh Issue Size | 27,44,000 shares | 10,24,000 shares |
| Fresh Issue Size (Amount) | up to ₹8.23 Cr | up to ₹1.54 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 27,44,000 shares | 10,24,000 shares |
| Issue Size Total (Amount) | up to ₹8.23 Cr | up to ₹1.54 Cr |
Fourth Dimension Solutions IPO opens on Dec 30, 2015, while Ganga Pharmaceuticals IPO opens on Jan 29, 2016. The closing date of Fourth Dimension Solutions IPO and Ganga Pharmaceuticals IPO is Jan 07, 2016, and Feb 09, 2016, respectively.
| Fourth Dimension Solutions IPO | Ganga Pharmaceuticals IPO | |
|---|---|---|
| Issue Open | Dec 30, 2015 | Jan 29, 2016 |
| Issue Close | Jan 07, 2016 | Feb 09, 2016 |
| Basis Of Allotment (Tentative) | Jan 15, 2016 | Feb 16, 2016 |
| Listing date (Tentative) | Jan 22, 2016 | Feb 22, 2016 |
Fourth Dimension Solutions IPO P/E ratio is , as compared to Ganga Pharmaceuticals IPO P/E ratio of .
| Fourth Dimension Solutions IPO | Ganga Pharmaceuticals IPO | |
|---|---|---|
| Promoter Shareholding (Pre-Issue) | 99.98% | 91.05% |
| Promoter Shareholding (Post-Issue) | 73.43% | 68.09% |
| Market Cap | ₹32.68 Cr. | ₹60.92 Cr. |
| RoNW | 72.49 | 1.27 |
In the Fourth Dimension Solutions IPO Retail Individual Investors (RII) are offered 13,72,000 shares while in Ganga Pharmaceuticals IPO retail investors are offered 13,72,000 shares. Qualified Institutional Buyers (QIB) are offered in Fourth Dimension Solutions IPO and 0 shares in Ganga Pharmaceuticals IPO.
| Fourth Dimension Solutions IPO | Ganga Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | |
| Market Maker Reservation | 1,48,000 shares | 0 shares |
| QIB | 0 shares | |
| NII | 13,72,000 shares | 5,12,000 shares |
| RII | 13,72,000 shares | 5,12,000 shares |
| Employee | 0 shares | |
| Total | 27,44,000 shares | 10,24,000 shares |
Fourth Dimension Solutions IPO subscribed 2.06x in total, whereas Ganga Pharmaceuticals IPO subscribed 1.09x.
| Fourth Dimension Solutions IPO | Ganga Pharmaceuticals IPO | |
|---|---|---|
| NII (times) | 2.17x | 1.16x |
| RII (times) | 1.94x | 1.03x |
| Total (times) | 2.06x | 1.09x |
